NILOTHERAPY 200

NILOTHERAPY 200 is a targeted anticancer therapy formulated with Nilotinib (200 mg), designed for the effective management of certain types of blood cancers, particularly chronic myeloid leukemia (CML). Developed with advanced pharmaceutical standards by Steris Healthcare Pvt. Ltd., NILOTHERAPY 200 offers precision treatment by directly targeting cancer cells while minimizing damage to healthy cells.

What is NILOTHERAPY 200?

NILOTHERAPY 200 contains Nilotinib (200 mg), a second-generation tyrosine kinase inhibitor (TKI). It is primarily used in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia, a condition where abnormal white blood cells grow uncontrollably.

Nilotinib works by blocking specific proteins (BCR-ABL tyrosine kinase) responsible for the growth of cancer cells, thereby slowing or stopping the progression of the disease.

How NILOTHERAPY 200 Works

In CML, a genetic mutation leads to the formation of the BCR-ABL protein, which promotes uncontrolled cell division. Nilotinib in NILOTHERAPY 200 selectively inhibits this protein, preventing cancer cell proliferation and inducing apoptosis (cell death).

This targeted mechanism ensures effective treatment with fewer side effects compared to conventional chemotherapy.

Key Benefits of NILOTHERAPY 200

• Targeted Cancer Therapy: Specifically blocks cancer-causing proteins
• Effective in CML Management: Proven efficacy in chronic and accelerated phases
• Reduces Disease Progression: Helps control abnormal white blood cell growth
• Improved Tolerability: Compared to traditional chemotherapy
• Supports Long-Term Treatment: Suitable for ongoing cancer management
• Enhances Quality of Life: Helps patients maintain daily activities

Uses of Nilotinib (200 mg)

NILOTHERAPY 200 is indicated for:

• Treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
• Patients resistant or intolerant to prior therapies (such as imatinib)
• Management of chronic and accelerated phase CML

Dosage and Administration

NILOTHERAPY 200 should be taken strictly as prescribed by an oncologist or healthcare professional.

General Guidelines:

• Usually taken twice daily on an empty stomach
• Avoid food at least 2 hours before and 1 hour after taking the capsule
• Swallow capsules whole with water; do not crush or chew

Dosage may vary depending on the patient’s condition, response to treatment, and medical history.

Important Precautions

Before using NILOTHERAPY 200, inform your doctor if you have:

• Heart conditions (especially QT prolongation)
• Liver or pancreatic disorders
• Electrolyte imbalance (low potassium or magnesium)
• History of bleeding disorders

Safety Measures:

• Regular ECG monitoring may be required
• Blood tests should be conducted to monitor liver function and blood counts
• Avoid grapefruit or grapefruit juice during treatment
• Not recommended during pregnancy or breastfeeding unless advised

Possible Side Effects

Like all anticancer medications, NILOTHERAPY 200 may cause side effects. Common ones include:

• Nausea and vomiting
• Headache
• Fatigue
• Rash or itching
• Constipation or diarrhea

Serious side effects may include:

• Heart rhythm changes (QT prolongation)
• Liver dysfunction
• Pancreatitis
• Low blood cell counts

Immediate medical attention is required if severe symptoms occur.

Storage Instructions

• Store below 25°C in a dry place
• Protect from light and moisture
• Keep out of reach of children

Why Choose NILOTHERAPY 200?

NILOTHERAPY 200 by Steris Healthcare Pvt. Ltd. is manufactured with strict quality control to ensure safety, efficacy, and consistency. Its targeted action makes it a preferred choice among oncologists for treating CML with precision.

The product is designed to meet the growing demand for advanced cancer therapies in India, offering patients access to effective and affordable treatment options.

Conclusion

NILOTHERAPY 200 (Nilotinib 200 mg) is a modern, targeted therapy that plays a crucial role in managing chronic myeloid leukemia. With its precise mechanism of action, proven effectiveness, and patient-friendly dosing, it offers hope for better disease control and improved quality of life.

For optimal results, always use NILOTHERAPY 200 under the guidance of a qualified healthcare professional and adhere strictly to prescribed monitoring protocols.

You have not enough Humanizer words left. Upgrade your Surfer plan.